» Articles » PMID: 15319366

Platelet Factor 4 in Conjunction with IL-4 Directs Differentiation of Human Monocytes into Specialized Antigen-presenting Cells

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2004 Aug 21
PMID 15319366
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Recent evidence suggests that platelets are not only involved in haemostatic processes but also modulate immune responses. As antigen-presenting cells (APC) are of crucial importance for the regulation of immunity, in this study we wanted to define the role of platelet factor 4 (PF-4) as one of the major platelet-derived chemokines on the transition of monocytes into APCs. Our experiments show that within 3 days PF-4 in conjunction with IL-4 induces a rapid differentiation of monocytes into APC. These PFAPC (PF-4/IL-4 differentiated APC) display unique phenotypical and functional characteristics setting them apart from macrophages and conventional dendritic cells. Functional studies revealed that PFAPC preferentially stimulated proliferation of lymphocytes and lytic NK activity while they induced only moderate cytokine responses. Beyond day 3 of differentiation, PFAPC became less immunostimulatory and maintained their capacity to phagocytose particulate material even after LPS-induced maturation. These experiments uncover a previously unknown role for the platelet-derived CXC-chemokine PF-4 in differentiation of human APC. Our data further support the newly discovered function of platelets in immunomodulation and provide new evidence for a rapid transition of monocytes into APC under the influence of inflammatory stimuli.

Citing Articles

CD150‑dependent activation of EBV‑transformed B cells induces the differentiation of peripheral blood monocytes via the secretion of multiple cytokines.

Kim H, Seo I, Hur D Int J Mol Med. 2024; 54(3).

PMID: 39027993 PMC: 11265835. DOI: 10.3892/ijmm.2024.5403.


Proteomics reveals differential adsorption of angiogenic platelet lysate proteins on calcium phosphate bone substitute materials.

da Costa Marques R, Simon J, dArros C, Landfester K, Jurk K, Mailander V Regen Biomater. 2022; 9:rbac044.

PMID: 35936551 PMC: 9348553. DOI: 10.1093/rb/rbac044.


Beyond Hemostasis: Platelet Innate Immune Interactions and Thromboinflammation.

Mandel J, Casari M, Stepanyan M, Martyanov A, Deppermann C Int J Mol Sci. 2022; 23(7).

PMID: 35409226 PMC: 8998935. DOI: 10.3390/ijms23073868.


Platelet-Released Factors: Their Role in Viral Disease and Applications for Extracellular Vesicle (EV) Therapy.

Ostermeier B, Soriano-Sarabia N, Maggirwar S Int J Mol Sci. 2022; 23(4).

PMID: 35216433 PMC: 8876984. DOI: 10.3390/ijms23042321.


Differential Effects of Platelet Factor 4 (CXCL4) and Its Non-Allelic Variant (CXCL4L1) on Cultured Human Vascular Smooth Muscle Cells.

Kaczor D, Kramann R, Hackeng T, Schurgers L, Koenen R Int J Mol Sci. 2022; 23(2).

PMID: 35054772 PMC: 8775478. DOI: 10.3390/ijms23020580.